Spectricity raises €14m in Series B round
Belgian semiconductor specialist Spectricity BV has baged €14m to speed up the development of mobile hyperspectral sensors for medical applications.
Atlantic Bridge, Capricorn Fusion China Fund, Shanghai Semiconductor Equipment and the Material Fund (SSMEF) led the Series B financing round alongside Belgium Series A investors imec.xpand and XTRION. With the fresh capital, Spectricity has got €20m in total funding to date.
"This is a major milestone for the deployment of our chip size hyperspectral sensor and imager solutions for mass market mobile devices and applications, said Vincent Mouret, Spectricity CEO. Hyperspectral sensing allows to measure heartbeat, oxygen saturation of the blood or skin hydration of your skin using a smartphone or a wearable device. Spectricitys patented, spectral sensing technology enhances existing camera sensors by fusing data with other image and 3D sensors in the devices to provide augmented real-time data, advanced user-environment interfacing, and big data analysis.
Following more than 10 years of research at imec, a world-leading R&D and innovation hub in nano-electronics and digital technologies, Spectricity was founded in 2018 by a team including research engineers of imec. Semiconductor industry veterans, CEO Vincent Mouret who joined the company last April and Chairman of the Board, Pieter Vorenkamp, ex-Senior Vice President of Broadcom, helped to productize the technology and scale the company.